JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Wnt/β-catenin

A3512 IWP-2
2 Citation

Summary: Wnt production inhibitor,PORCN inhibitor

≥23.35 mg/mL
A3011 CHIR-99021 (CT99021)
30 Citation

Target: GSK-3

Summary: GSK-3 inhibitor

≥23.27 mg/mL
A8217 ICG 001
8 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL
A8685 Wnt-C59
2 Citation

Target: PORCN

Summary: PORCN inhibitor,highly potent and selective

.95 mg/mL

insoluble in H2O; ≥18
B2305 IWP-L6

Summary: Porcupine inhibitor,highy potent

≥22.45 mg/mL
A3413 FH535

Summary: Wnt/B-catenin inhibitor

≥36.1 mg/mL
A3785 Salinomycin

Target: Antibiotic

Summary: Polyether ionophore antibiotic;anti-cancer
B2306 IWR-1-endo
1 Citation

Summary: Potent Wnt signaling inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.45 mg/mL
B4687 iCRT 14

Summary: CRT inhibitor

insoluble in EtOH; insoluble in H2O; ≥18.75 mg/mL
A4529 JW 55

Summary: PARP domain inhibitor

insoluble in H2O; ≥19.25 mg/mL